St. Jude Medical announces CE Mark approval of Assura defibrillators St. Jude Medical announced European CE Mark approval of the Assura portfolio of implantable cardioverter defibrillators and cardiac resynchronization therapy defibrillators.
News For STJ From The Last 14 Days
Check below for free stories on STJ the last two weeks.
St. Jude Medical's 3-D vessel reconstruction system approved in Europe St. Jude Medical announced CE Mark approval of its Ilumien Optis PCI Optimization System, a new technology designed to provide physicians with a comprehensive disease assessment tool for treating patients with coronary artery disease. St. Jude Medical is the only company to provide these tools together in an integrated platform.